Introduction
Hepatic sclerosing hemangioma is a very rare benign tumor, characterized by fibrosis and hyalinization occurring in association with degeneration of a hepatic cavernous hemangioma [1] . Because the radiological features can resemble those of hepatic malignancies such as metastatic liver cancer, intrahepatic cholangiocarcinoma (IHCC), or fibrolamellar hepatocellular carcinoma (FLC), definitive preoperative diagnosis may be difficult, particularly in cases showing multiple tumors. Laparoscopic hepatectomy has become a useful method of diagnostic therapy for patients with liver tumors with the progress of surgical techniques and laparoscopic devices [2] . We report here a rare case of multiple hepatic sclerosing hemangioma mimicking metastatic liver tumor that was successfully treated using laparoscopic surgery.
Case presentation
A previously healthy 67-year-old woman presented with blood in the stool. Colonoscopy showed a type 2 sigmoid cancer. Examination of biopsy specimens revealed moderately differentiated adenocarcinoma. Serum levels of carcinoembryonic antigen (CEA) and carbohydrate antigen (CA)19-9 were 1.8 ng/mL and 5 U/mL, respectively. Computed tomography (CT) showed a ringenhancing 28 mm exophytic lesion arising from S6 of the liver (Fig. 1a) . No additional hepatic lesions were identified on CT. On dynamic contrast-enhanced magnetic resonance imaging (MRI), T1-weighted imaging showed a signal-hypointense mass in S6 (Fig. 1b) . After contrast enhancement, the mass showed a similar enhancement pattern to that seen on dynamic CT. T2-weighted imaging showed a mass with heterogeneous signal intensity. similar small nodule 11 mm in diameter was also detected in S1 (Fig. 1b) . These findings led to a diagnosis of advanced sigmoid cancer with multiple liver metastases. The patient first underwent single-incision laparoscopic sigmoidectomy in April 2013. Examination of surgical specimens revealed moderately differentiated adenocarcinoma invading the serosa, with no lymph node metastases. Serum levels of CEA and CA19-9 remained within normal limits throughout the course. CT showed no changes in tumor size. In June 2013, the patient underwent laparoscopic partial hepatectomy of S1 and S6, and cholecystectomy. She was placed in a supine position with legs apart. A 12 mm blunt tip trocar for a 10 mm flexible scope was placed at the umbilicus, through which carbon dioxide gas was delivered. Pneumoperitoneum was controlled to a pressure of 8 mm Hg. An additional three trocars were located as shown in Fig. 2 . Intraoperative laparoscopic observation showed two welldemarcated, white tumors on the surface of S1 and S6 (Fig. 3 ). The lesser omentum was sectioned and the hepatoduodenal ligament was encircled by tape to be used as a tourniquet for complete interruption of blood inflow to the liver, only if necessary. After laparoscopic cholecystectomy was performed, partial hepatectomy of S1 and S6 was performed using laparoscopic coagulation shears, an ultrasound surgical aspirator, and a vessel-sealing device, considering the possibility that these liver tumors represented metastases from the sigmoid colon cancer. The operative time was 345 min. Blood loss was minimal. Histopathological examination showed that the tumors mainly comprised hyalinized tissue and collagen fibers with sporadic vascular space on sections stained with hematoxylin and eosin, yielding a diagnosis of multiple hepatic sclerosing hemangioma (Fig. 4) . The postoperative course was uneventful and the patient was discharged on postoperative day 8. No evidence of recurrence has been seen during the 21 months of follow-up.
Discussion
The clinical course of this patient suggests two important clinical issues. First, sclerosing hemangioma should be included among the differential diagnoses of multiple liver tumors in patients with colorectal cancer. Sclerosing hemangioma is a rare type of hepatic hemangioma composed of abundant acellular hyalinized tissue in which small vessels are occasionally seen [1] . Only 17 resected cases, including the present case, with detailed information on patients with hepatic sclerosing hemangioma have been reported in the English literature (Table 1) [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . To the best of our knowledge, this report is the first to describe multiple hepatic sclerosing Fig. 3 . Intraoperative laparoscopic observation.
Two well-demarcated, white tumors are apparent on the surface of S6 (a) and S1 (b). hemangiomas treated by laparoscopic surgery. A review of previously reported cases revealed that sclerosing hemangioma tends to occur more frequently in women than in men (6 men, 10 women), and occurs most frequently in middle to elder age, with a median age of 65 years (range, 41-84 years). Previous reports have shown no frequent location in the liver, with a median size of 42.5 mm (range, 8-130 mm). Enhanced CT showed the ring-like pattern of enhancement characteristic of adenocarcinoma in 11 (65%) of 17 cases. The MRI findings of sclerosing hemanigioma were also very different from typical cavernous hemangioma, appearing low on T1-weighted imaging and high on T2-weighted imaging, categorized as non-specific, and still not excluding adenocarcinoma. Such radiological findings might lead to a preoperative diagnosis of hypovascular adenocarcinoma, including metastatic liver cancer, hepatocellular carcinoma (HCC), IHCC, and FLC. In our case, differentiating the lesions from metastatic liver tumors was quite difficult, because the radiological findings were closely compatible with liver metastases and multiple tumors were evident. An elevated level of CEA in peripheral blood is a strong indicator of hepatic metastasis from colorectal cancer. Tartter et al. [18] described the sensitivity and specificity of CEA elevation to >5 ng/ml in patients with liver metastasis from colorectal cancer as 81% and 72%, respectively. Conversely, in our patient, the CEA level remained within normal limits during the course. PET/CT was not performed in this case, but could have detected the likely benign nature of this sclerosing hemangioma. The sensitivity and specificity of PET/CT in patients with recurrent colorectal cancer have been reported as 97% and 76%, respectively [19] . However, PET provides insufficient anatomical information, although this lack of information has improved with the integration of CT into PET. MRI provides additional accuracy to liver contrast-enhanced CT in the assessment of a patient's suitability for hepatic resection. The second important clinical point is that laparoscopic hepatectomy is useful as a diagnostic therapy for undiagnosed multiple liver tumor. Fine-needle biopsy can differentiate sclerosing hemangioma from colorectal metastasis, but can potentially lead to rupture [20] or seeding of cancer cells. We believe that surgical resection of suspected colorectal metastases in the present patient was safe, and provided both a diagnosis and a solution to cancer therapy. With the progress of surgical techniques and devices, laparoscopic hepatectomy has become a realizable option for patients with liver tumors. Iwahashi et al. [2] reported that blood loss was significantly less with laparoscopic hepatectomy than with open hepatectomy, and the hospital stay with laparoscopic hepatectomy tended to be shorter. Regarding long-term outcomes, they found no significant differences in overall or disease-free survival between the laparoscopic and open hepatectomy groups. The pathological findings in this case indicate that our patient did not need surgical intervention, but laparoscopic partial hepatectomy provided less blood loss, a shorter duration of hospitalization, and good cosmetic results, and also proved useful in diagnostic therapy.
Conclusion
Sclerosing hemangioma should be included among the differential diagnoses of multiple liver tumors in patients with colorectal cancer. Laparoscopic hepatectomy is useful for diagnostic therapy for undiagnosed multiple liver tumors.
Conflict of interest
Masaki Wakasugi and the other co-authors have no conflict of interest to declare.
Funding
None.
Ethical approval
Written informed consent was obtained from the patients for the information to be included in our manuscript. Her information has been de-identified to the best of our ability to protect his privacy.
Author contributions
Each author participated in writing the manuscript and all agreed to accept equal responsibility for the accuracy of the content of the paper.
